What is ClinSmart?
ClinSmart operates as a comprehensive Contract Research Organization with a specialized focus on imaging and nuclear medicine. By integrating the expertise of ABX-CRO Inc, the company has developed a unique service portfolio that addresses the complex requirements of theranostics. Their operational model provides end-to-end clinical and imaging services, maintaining a presence across the United States, the European Union, and India. This integrated approach allows ClinSmart to deliver highly focused, personalized results for pharmaceutical and biotech clients navigating the rigorous demands of clinical trials.
How much funding has ClinSmart raised?
ClinSmart has raised a total of $72K across 1 funding round:
Debt
$72K
Debt (2021): $72K with participation from PPP
Key Investors in ClinSmart
PPP
Public-Private Partnership
What's next for ClinSmart?
The recent infusion of capital is earmarked for scaling the company's international infrastructure and enhancing its technological capabilities in nuclear medicine. As ClinSmart moves through this significant Series B/C stage, the focus will likely shift toward optimizing its global supply chain and expanding its footprint in emerging markets. By leveraging its combined expertise in theranostics, the firm is well-positioned to capture a larger share of the specialized CRO market, driving long-term value through operational excellence and strategic service diversification. Keywords: ClinSmart, Contract Research Organization, Theranostics, Nuclear Medicine, Clinical Trials, Biotech Investment, CRO Expansion, Healthcare Capital.
See full ClinSmart company page
